REPLIGEN CORP (RGEN) › Cost of RevenueREPLIGEN CORP (RGEN) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2016: $47.12M2017: $67.05M2018: $86.53M2019: $119.10M2020: $156.63M2021: $279.28M2022: $345.83M2023: $353.92M2024: $359.79M2025: $352.01M$352.01M2016Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$352.01M-2.2%2024$359.79M+1.7%2023$353.92M+2.3%2022$345.83M+23.8%2021$279.28M+78.3%2020$156.63M+31.5%2019$119.10M+37.6%2018$86.53M+29.1%2017$67.05M+42.3%2016$47.12M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share